Fluocinolone
Links shared publicly online about this topic
fluocinolone insert effective for diabetic retinopathy
eyedocnews.com — “fluocinolone helped diabetic retinopathy patients who already failed laser.” View full resource at eyedocnews.com
Most Recently Shared on May 12, 2011 at 10:01 am By:
Dr. Ari Weitzner Doctor, Ophthalmologist, and Physician
Discuss: Fluocinolone Acetonide Insert Effective For Diabetic Retinopathy: Archives: In yet what seems another n... http://bit.ly/jwfddR
fluocinolone acetonide effective in diabetic macular edema
eyedocnews.com — “fluocinolone acetonide intravitreal steroid implant was effective in persistent diabetic macular edema, but with high risk of elevated pressure and cataract” View full resource at eyedocnews.com
Most Recently Shared on August 29, 2011 at 10:51 am By:
Dr. Ari Weitzner Doctor, Ophthalmologist, and Physician
Discuss: Fluocinolone Acetonide Implant Effective In Diabetic Macular Edema: Ophthalmology: The fluocinolone ace... http://t.co/0StA1Za
Iluvien For Diabetic Macular Edema Turned Down By FDA
medicalnewstoday.com — “Investigational drug Iluvien (fluocinolone acetonide intravitreal insert) for the treatment of diabetic macular edema cannot be approved in its present form, the FDA (Food and Drug Administration)” View full resource at medicalnewstoday.com
Most Recently Shared on December 24, 2010 at 10:09 pm By:
Iluvien For Diabetic Macular Edema Turned Down By FDA http://bit.ly/ijVqiA
Diabetic Macular Edema Drug Iluvien Gets FDA Priority Review
medicalnewstoday.com — “Iluvien(R) (fluocinolone acetonide intravitreal insert), an investigational sustained drug delivery system that releases sub-microgram levels of fluocinolone acetonide for DME (diabetic macular e” View full resource at medicalnewstoday.com
Most Recently Shared on August 31, 2010 at 6:33 pm By:
Scott Strumello Patient Expert
Diabetic Macular Edema Drug Iluvien Gets FDA Priority Review: http://bit.ly/c1lNuz
Newly-Published Peer-Reviewed Paper Shows Durasert Device Was Neuroprotectant In Retinitis Pigmentosa Model
medicalnewstoday.com — “pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in the development of ophthalmic sustained release drug delivery products, today said that a recently-published peer reviewed scientific paper showe” View full resource at medicalnewstoday.com
Most Recently Shared on April 9, 2010 at 2:10 pm By:
Newly-Published Peer-Reviewed Paper Shows Durasert Device Was Neuroprotectant In Retinitis Pigmentosa Model http://mnt.to/3zZS #eyehealth
FDA Issues Complete Response Letter Regarding New Drug Application for Iluvien
drugs.com — “Iluvien (fluocinolone acetonide) is a new drug formulation in development for the treatment of Diabetic Macular Edema. Iluvien information includes news, clinical trial results and side effects.” View full resource at drugs.com
Most Recently Shared on January 9, 2011 at 12:10 am By:
Drugs and Devices OW OW Health
FDA Issues Complete Response Letter Regarding New Drug Application for Iluvien: WATERTOWN, Mass.--(BUSINES... http://bit.ly/eiHec9 #drug
pSivida Announces Resubmission of New Drug Application for Iluvien
drugs.com — “Iluvien (fluocinolone acetonide) is a new drug formulation in development for the treatment of Diabetic Macular Edema. Iluvien information includes news, clinical trial results and side effects.” View full resource at drugs.com
Most Recently Shared on May 13, 2011 at 11:06 pm By:
Drugs and Devices OW OW Health
pSivida Announces Resubmission of New Drug Application for Iluvien: WATERTOWN, Mass.--(BUSINESS WIRE)--May... http://bit.ly/m19oHW #drug
Diabetic Macular Edema Drug Iluvien Gets FDA Priority Review | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com
keyvive.com — “Diabetic Macular Edema Drug Iluvien Gets FDA Priority Review | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com” View full resource at keyvive.com
Most Recently Shared on September 1, 2010 at 2:10 pm By:
Diabetic Macular Edema Drug Iluvien Gets FDA Priority Review: Iluvien(R) (fluocinolone… http://goo.gl/fb/bDodP
Alimera Sciences resubmits new drug application
osnsupersite.com — “ATLANTA — Alimera Sciences has resubmitted a new drug application for fluocinolone acetonide implants to address a complete response let” View full resource at osnsupersite.com
Most Recently Shared on May 16, 2011 at 5:00 pm By:
#Alimera Sciences resubmits new drug application: http://ht.ly/4VAGD
Retisert implant in sympathetic ophthalmia - Ophthalmology Times Europe
oteurope.com — “The fluocinolone acetonide (Retisert; Bausch & Lomb) surgical implant can prevent blindness in cases of sympathetic ophthalmia (SO), according to research at the University of Iowa, US.” View full resource at oteurope.com
Most Recently Shared on March 18, 2009 at 12:30 pm By:
Ophthalmology Times Ophthalmology and Health Magazine
Can Bausch & Lomb's #Retisert implant prevent blindness in sympathetic #ophthalmia? http://ow.ly/11Mt
Avoiding atrophy: Triple combination cream unlikely to impact skin - - ModernMedicine
modernmedicine.com — “Dallas — Long-term use of a triple-combination cream for melasma (fluocinolone acetonide, hydroquinone, tretinoin; TriLuma, Galderma) is effective and unlikely to cause skin atrophy, according to a recent study.” View full resource at modernmedicine.com
Most Recently Shared on September 17, 2009 at 9:11 pm By:
UT Southwestern News Medical School
Can a cream help you avoid #atrophy? UTSW dermatologist provides the answer: http://bit.ly/20eC1
Phase 3 studies of Iluvien for the treatment of diabetic macular edema (DME) - MPR
empr.com — “pSivida Corporation announced top-line readout results from two Phase 3 studies of Iluvien (sustained release fluocinolone acetonide insert) for the treatment of diabetic macular edema (DME).” View full resource at empr.com
Most Recently Shared on February 4, 2011 at 6:25 pm By:
MPR News: Phase 3 studies of Iluvien for the treatment of diabetic macular edema (DME): pSivida Corporation anno... http://bit.ly/gDuoFl
Phase 3 studies of Iluvien for the treatment of diabetic macular edema (DME) - ONA
oncologynurseadvisor.com — “pSivida Corporation announced top-line readout results from two Phase 3 studies of Iluvien (sustained release fluocinolone acetonide insert) for the treatment of diabetic macular edema (DME).” View full resource at oncologynurseadvisor.com
Most Recently Shared on February 4, 2011 at 6:36 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Phase 3 studies of Iluvien for the treatment of diabetic macular edema (DME) http://goo.gl/fb/ZLLpF
Phase 3 Study of Iluvien for Diabetic Macular Edema - ONA
oncologynurseadvisor.com — “pSivida Corp. announced new data from its Phase 3 study of Iluvien (sustained release fluocinolone acetonide insert) for the treatment of diabetic macular edema.” View full resource at oncologynurseadvisor.com
Most Recently Shared on May 3, 2011 at 3:59 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Phase 3 Study of Iluvien for Diabetic Macular Edema http://goo.gl/fb/e9mrq
Phase 3 Study of Iluvien for Diabetic Macular Edema - MPR
empr.com — “pSivida Corp. announced new data from its Phase 3 study of Iluvien (sustained release fluocinolone acetonide insert) for the treatment of diabetic macular edema.” View full resource at empr.com
Most Recently Shared on May 3, 2011 at 4:06 pm By:
MPR News: Phase 3 Study of Iluvien for Diabetic Macular Edema: pSivida Corp. announced new data from its Phase 3... http://bit.ly/iisxtm
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Dr. Ari Weitzner
Brooklyn, NY Ophthalmologist; Editor of EyeDocNews; Founder of Share Medical Space
-
Dr. Ari Weitzner
Brooklyn, NY Ophthalmologist; Editor of EyeDocNews; Founder of Share Medical Space
-
Health News
Live Health News!
Advertisement
